Literature DB >> 1877180

Diagnosis and antibiotic treatment of community-acquired pneumonia.

J E Rodnick1, J K Gude.   

Abstract

Only a few pathogens cause most community-acquired pneumonias. In outpatients, treatment is empiric, based on the results of chest films, leukocyte counts, and Gram's stains (if available). Antibiotics must always cover pneumococci and should cover Mycoplasma pneumoniae in young adults and during epidemic periods. A follow-up chest film in smokers and those older than 40 years is strongly recommended. In inpatients, the evaluation and treatment are tailored to individual cases. A search for a wider range of causes, using invasive tests if necessary, is undertaken, and all likely pathogens should be covered with the initial antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1877180      PMCID: PMC1002786     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  20 in total

Review 1.  Chlamydia pneumoniae, strain TWAR.

Authors:  J T Grayston
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

2.  Etiology of community-acquired pneumonia in out-patients.

Authors:  E Berntsson; T Lagergård; O Strannegård; B Trollfors
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

Review 3.  Acute lower respiratory tract infections in nonhospitalized children.

Authors:  F W Denny; W A Clyde
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406

Review 4.  Aetiology of community-acquired pneumonia in hospital treated patients.

Authors:  H Holmberg
Journal:  Scand J Infect Dis       Date:  1987

5.  Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations.

Authors:  M Lévy; F Dromer; N Brion; F Leturdu; C Carbon
Journal:  Chest       Date:  1988-01       Impact factor: 9.410

6.  Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study.

Authors:  M J Fine; D N Smith; D E Singer
Journal:  Am J Med       Date:  1990-12       Impact factor: 4.965

Review 7.  Using erythromycin. Some helpful observations.

Authors:  P A Latare; P A Setness
Journal:  Postgrad Med       Date:  1989-07       Impact factor: 3.840

8.  Prospective study of the aetiology and outcome of pneumonia in the community.

Authors:  M A Woodhead; J T Macfarlane; J S McCracken; D H Rose; R G Finch
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

9.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study.

Authors:  T J Marrie; H Durant; L Yates
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

Review 10.  Branhamella catarrhalis infections.

Authors:  P W Wright; W G Avery
Journal:  Am Fam Physician       Date:  1989-02       Impact factor: 3.292

View more
  4 in total

Review 1.  Cost-effective treatment of lower respiratory tract infections.

Authors:  J C Garrelts; A M Herrington
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

Review 2.  Community-acquired pneumonia in adults.

Authors:  D Y Sue
Journal:  West J Med       Date:  1994-10

3.  Community acquired, nursing home acquired and hospital acquired pneumonia: A five-year review of the clinical, bacteriological and radiological characteristics.

Authors:  C Chow; L Lee-Pack; N Senathiragah; M Rawji; M Chan; C Chan
Journal:  Can J Infect Dis       Date:  1995-11

4.  Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia.

Authors:  F Trémolières; F de Kock; N Pluck; R Daniel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.